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Abstract
Background:  In the context of ongoing work to develop the next iteration of psychiatric
classification systems, we briefly review the performance of current systems against their own
stated objectives, for two major diagnostic groupings.
Discussion: In the major groupings of schizophrenia and depression, experience over the last 50
years has highlighted particular inadequacies in the utility and validity of available classifications.
Summary: Advances in psychiatric knowledge and practice notwithstanding, present classification
systems would be enhanced by the incorporation of dimensional components. Minor tinkering with
current systems will reflect only a missed opportunity. Improving classification will facilitate quality
improvement of mental health systems.
Background
As a specialised domain within health sciences, psychiat-
ric diagnostic practice has evolved under the influence of
the biomedical model, stimulated in part by the success of
rigorous and useful models of scientific classification,
such as the periodic table and Linnaean biological taxon-
omy[1].
Systematic classifications in psychiatry were first recognis-
ably developed by Pinel, but it is usually accepted that we
owe most to the work of Kraepelin and Bleuler[1]. The
labels available for mental disorders have evolved from
those baselines, with periodic, formal re-evaluation under
the guidance of the World Health Organisation, as new
editions of the International Classification of Diseases
(ICD) have been developed [2]. Also widely used is the 4th
Edition of the Diagnostic and Statistical Manual (DSM-
IV) of the American Psychiatric Association[3].
In general, psychiatric literature, service organisation and
funding, clinicians and researchers have worked within
this framework. Nonetheless, there has always been a
trickle of thoughtful dissenters and research based ques-
tions raised, sometimes about the fundamental approach,
but more often about the detail [4-9].
Chapter V of ICD-10, the Classification of Mental or
Behavioural Disorders[2] "...is intended for general clini-
cal, educational and service use." The Text Revision of
DSM-IV[3] is more specific "our highest priority has been
to provide a helpful guide to clinical practice," amplifying
this to include: -
• A means by which the profession communicates briefly
and clearly within itself about clinically recognisable con-
ditions for which it has professional responsibility for
diagnosis, care, or research.
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￿ When possible, a useful guide to current treatments.
￿ Information about the likely outcome of psychiatric disor-
ders with and without treatment.
￿ What is known of aetiology or pathophysiological proc-
esses.
The specificity apparent in the DSM guiding principles
accords with the oft quoted views of Robins and Guze[10]
on comprehensive criteria for evaluating the validity of a
psychiatric disorder. Such demanding criteria are far from
being realized for many psychiatric disorders [11]. Recent
work in Australasia, South America and East Asia suggests
that practising psychiatrists have more limited views, or
expectations, on the purpose of psychiatric classification
[12]. It remains an open question whether the Robins and
Guze criteria need to be applied and implemented more
effectively, or rethought altogether.
From the above, we conclude that psychiatric classifica-
tory systems are intended to facilitate communication of
information regarding:
￿ Description of disorders in order to promote under-
standing by colleagues, patients, and others
￿ Pathogenesis
￿ Indicated treatment choices
￿ Prognosis
￿ Categories useful for epidemiology, outcomes and other
research
Below, we consider schizophrenia and depression, the
two groups of diagnoses most commonly used in psychi-
atry. For each diagnostic group we note key published per-
spectives on the performance of current classification
against the above objectives.
Schizophrenia
Current classificatory descriptions of schizophrenia are
detailed, precise and specific, and as such allow reliable
communication regarding how the disorder 'feels' to
those affected, and 'looks' to clinicians and family. Classi-
fications achieved an acceptable degree of inter-rater reli-
ability in field trials[2,3] but perform far less reliably in
standard clinical practice[11]. The 37 four-digit codes
available under the ICD-10 general category of schizo-
phrenia provide a degree of detail likely to be irrelevant in
many countries [13].
There is little in either ICD or DSM regarding aetiology, an
important shortcoming in light of evidence that both
genetics and environment, separately and in combina-
tion, confer risk for this disorder in various populations
[14,15]. There is also evidence of  physiological, anatom-
ical and immunological abnormalities in  schizophrenia
that strongly suggest one or more brain pathologies
[16,17]. It follows that improved diagnostic validity will,
inter alia, magnify the signal-to-noise ratio for detecting
causal mechanisms operating in schizophrenia, particu-
larly if there exist distinct biological or other pathogenic
subgroups. Equally, better mechanistic understanding of
schizophrenia will help to validate diagnostic subtypes,
and their treatment implications.
A key problem, evident since the time of Bleuler, has been
that the prognosis in 'schizophrenia' has appeared varia-
ble, from complete recovery to progressive dysfunction
and invalidism[18]. This problem prompted the delinea-
tion of 'schizophreniform disorder' in DSM, phenomeno-
logically identical to acute schizophrenia but with a brief
time course, more frequent remission, and better progno-
sis. Similarly, the work of Robins and Guze[10] indicates
that what has been called 'mild' or good prognosis schiz-
ophrenia is fundamentally different from typical or 'proc-
ess' schizophrenia and it may thus be a misnomer to refer
to the former as schizophrenia at all. Such clinical reason-
ing, bolstered by carefully collected outcome data and
accumulating evidence of pathogenic mechanisms, indi-
cates that a categorical definition of schizophrenia is likely
to remain valid, provided that similar disorders can be
reliably distinguished. A supplementary dimensional
description of phase and severity holds promise as a guide
to management and prognosis[19].
Treatment guidelines for schizophrenia include a variety
of psychosocial interventions, but centre around antipsy-
chotic drugs[18,20]. Other available psychotropics,
including mood stabilisers, antidepressants and hyp-
nosedatives, also have an apparent role, raising serious
questions about any specificity between diagnosis and
indicated medication. Moreover, clinical response to indi-
vidual or grouped agents is unpredictable, and treatment
decisions are influenced by many patient variables other
than diagnosis [18,20]. For example, treatment needs in
chronic psychosis are more powerfully predicted by symp-
tom intensity than by diagnosis per se [9].
Depression
Widespread debate about the validity of contemporary
classification of depression stems from the fact that the
therapeutic and prognostic implications of mood disorder
diagnosis have repeatedly proved to be unreliable. Thus
Parker [21] has argued convincingly that the concept of
major depression suffers from problems of both reliabilityInternational Journal of Mental Health Systems 2007, 1:7 http://www.ijmhs.com/content/1/1/7
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and validity, and crucially "fails the test of providing
meaningful information about aetiology, prognosis and
treatment". One perennial difficulty is establishing a valid
diagnostic threshold of symptom severity or functional
impairment – particularly problematic since everyone
experiences fluctuating depressive symptoms to some
extent. It is not surprising therefore that the use of the
diagnostic label 'depressive disorder' has created a spuri-
ous impression of understanding [22,23]. It does not tell
us why and how a person became depressed nor does it
indicate degree of disability, duration, or the risk to self or
others. Similarly, it does not inform us about what specific
treatment (e.g. ECT, antidepressant medication or psycho-
therapy) would be appropriate or helpful. Furthermore,
there is a disparity between the descriptive diagnostic
labels, the real life situation, and day-to-day clinical prac-
tice. This apparent lack of correspondence between diag-
nosis and disorder is partly related to the failure of
contemporary classification systems to recognise and
address the inherent boundary ambiguities in depressive
disorder[23]. The usefulness of diagnostic categories for
epidemiology, outcomes and other research in mood dis-
orders is likely to continue, but serious concerns regarding
validity call for consideration of dimensional diagnostic
alternatives [24].
Conclusion
This report highlights the degree to which the perform-
ance of ICD-10 and DSM-IV fall short of their own objec-
tives. It is time to acknowledge that the 'classification
emperor' is less well-clothed than our daily practice
requires [25]. Existing categories also constrain thinking
about how to measure and address unmet need in popu-
lations. New, more valid, means of classification need to
be developed, perhaps incorporating concepts derived
from non-categorical thinking. Dimensional classification
may, for example, usefully inform the description of uni-
polar depression, anxiety and personality disorders
[24,26]. A "quantitative" axis incorporating such dimen-
sions and other guides to treatment and progress, such as
disorder staging and substance use, is a classificatory evo-
lution whose time has come. For these disorders at least,
dimensional description offers potential advances in the
prediction of both treatment choice and longitudinal
course, while retaining improvements in inter-clinician
communication developed over the last 25 years. With
regard to the major psychoses, available evidence is more
supportive of the validity of categorical diagnoses but sug-
gests these need to be supplemented with dimensional or
illness-phase classification. Simplification of current,
overly  complex subcategories is clearly warranted; dimen-
sional measures retain complementary importance as pre-
dictors of impairment and prognosis.
Summary
Official systems of psychiatric classification have been
evolving for more than 100 years and underpin the organ-
isation of services, individual clinicians' work, and most
psychiatric research. Sporadic reviews have challenged the
validity and usefulness of some of the key categories in
ICD and DSM. This article reflects on classification system
performances against their own claimed objectives, in two
diagnostic areas. We conclude that evident inadequacies
can no longer be ignored and that dimensional
approaches to classification offer one way forward.
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